Nutrition 21 Growth Strategy: Increased Retail Presence, R&D Focus
This article was originally published in The Tan Sheet
Executive Summary
Nutrition 21 plans to increase its efforts in both the retail and R&D sides of its business to combat losses in the first two quarters of FY 2002
You may also be interested in...
Nutrition 21 Diachrome, Zeramax Sales To Be Backed By Research Initiatives
Nutrition 21 plans to support the broad launch of its Diachrome chromium picolinate/biotin blend with a relatively large-scale clinical study, according to President and CEO Gail Montgomery
Nutrition 21 Diachrome, Zeramax Sales To Be Backed By Research Initiatives
Nutrition 21 plans to support the broad launch of its Diachrome chromium picolinate/biotin blend with a relatively large-scale clinical study, according to President and CEO Gail Montgomery
Nutrition 21 Diachrome, Zeramax Sales To Be Backed By Research Initiatives
Nutrition 21 plans to support the broad launch of its Diachrome chromium picolinate/biotin blend with a relatively large-scale clinical study, according to President and CEO Gail Montgomery